Lu‐Jun Zhao

636 total citations
20 papers, 517 citations indexed

About

Lu‐Jun Zhao is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Lu‐Jun Zhao has authored 20 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Lu‐Jun Zhao's work include Lung Cancer Treatments and Mutations (9 papers), Neuroendocrine Tumor Research Advances (6 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Lu‐Jun Zhao is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Neuroendocrine Tumor Research Advances (6 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Lu‐Jun Zhao collaborates with scholars based in China and United States. Lu‐Jun Zhao's co-authors include Zhiyong Yuan, Mao-Bin Meng, Nicholas G. Zaorsky, Huan-Huan Wang, Ping Wang, Lei Deng, Chao Jiang, Hongqing Zhuang, Ping Wang and Ping Wang and has published in prestigious journals such as Scientific Reports, Cancer Letters and Oncotarget.

In The Last Decade

Lu‐Jun Zhao

19 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu‐Jun Zhao China 13 253 239 142 126 96 20 517
Huan-Huan Wang China 11 195 0.8× 151 0.6× 158 1.1× 103 0.8× 100 1.0× 13 461
Mao-Bin Meng China 13 261 1.0× 255 1.1× 169 1.2× 121 1.0× 122 1.3× 17 628
Dinu Stefan France 10 167 0.7× 204 0.9× 117 0.8× 67 0.5× 71 0.7× 29 441
Jun Sakakibara‐Konishi Japan 15 333 1.3× 249 1.0× 368 2.6× 87 0.7× 148 1.5× 74 745
Paul Lesueur France 10 225 0.9× 217 0.9× 113 0.8× 45 0.4× 58 0.6× 35 497
Jenny Ling‐Yu Chen Taiwan 14 133 0.5× 127 0.5× 72 0.5× 79 0.6× 51 0.5× 37 461
Qingting Huang China 12 99 0.4× 123 0.5× 158 1.1× 73 0.6× 112 1.2× 40 444
Irini Karapanagiotou‐Schenkel Germany 10 98 0.4× 167 0.7× 123 0.9× 38 0.3× 83 0.9× 16 435
László Mangel Hungary 11 226 0.9× 136 0.6× 111 0.8× 31 0.2× 202 2.1× 63 511
M Slavík Czechia 11 102 0.4× 191 0.8× 84 0.6× 55 0.4× 88 0.9× 50 439

Countries citing papers authored by Lu‐Jun Zhao

Since Specialization
Citations

This map shows the geographic impact of Lu‐Jun Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu‐Jun Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu‐Jun Zhao more than expected).

Fields of papers citing papers by Lu‐Jun Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu‐Jun Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu‐Jun Zhao. The network helps show where Lu‐Jun Zhao may publish in the future.

Co-authorship network of co-authors of Lu‐Jun Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Lu‐Jun Zhao. A scholar is included among the top collaborators of Lu‐Jun Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu‐Jun Zhao. Lu‐Jun Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Liming, Chingyun Cheng, Minglei Kang, et al.. (2017). Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer. Scientific Reports. 7(1). 9255–9255. 28 indexed citations
2.
Zhao, Lu‐Jun, Charles B. Simone, Chingyun Cheng, et al.. (2017). Receipt of thoracic radiation therapy and radiotherapy dose are correlated with outcomes in a retrospective study of three hundred and six patients with extensive stage small-cell lung cancer. Radiotherapy and Oncology. 125(2). 331–337. 28 indexed citations
3.
4.
Wang, Huan-Huan, Nicholas G. Zaorsky, Jie Lan, et al.. (2016). Mesenchymal stem cells generate pericytes to promote tumor recurrence via vasculogenesis after stereotactic body radiation therapy. Cancer Letters. 375(2). 349–359. 69 indexed citations
5.
Wang, Huan-Huan, Nicholas G. Zaorsky, Mao-Bin Meng, et al.. (2016). Stereotactic radiation therapy for oligometastases or oligorecurrence within mediastinal lymph nodes. Oncotarget. 7(14). 18135–18145. 22 indexed citations
6.
7.
Meng, Mao-Bin, et al.. (2015). The prognosis factor of adjuvant radiation therapy after surgery in uterine sarcomas. OncoTargets and Therapy. 8. 2339–2339. 4 indexed citations
8.
Meng, Mao-Bin, Huan-Huan Wang, Nicholas G. Zaorsky, et al.. (2015). Clinical evaluation of stereotactic radiation therapy for recurrent or second primary mediastinal lymph node metastases originating from non-small cell lung cancer. Oncotarget. 6(17). 15690–15703. 24 indexed citations
9.
Meng, Mao-Bin, Huan-Huan Wang, Nicholas G. Zaorsky, et al.. (2015). Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma. OncoTargets and Therapy. 437–437. 15 indexed citations
10.
Zhuang, Hongqing, Yihang Guo, Jun Wang, et al.. (2014). Experimental study on the regulation of erlotinib-induced radiosensitization with an anti-c-MET monoclonal antibody. Cancer Cell International. 14(1). 109–109. 8 indexed citations
11.
Meng, Mao-Bin, Huan-Huan Wang, Nicholas G. Zaorsky, et al.. (2014). Targeting pyruvate kinase M2 contributes to radiosensitivity of non-small cell lung cancer cells in vitro and in vivo. Cancer Letters. 356(2). 985–993. 58 indexed citations
12.
Meng, Mao-Bin, Nicholas G. Zaorsky, Lei Deng, et al.. (2014). Pericytes: A Double-Edged Sword in Cancer Therapy. Future Oncology. 11(1). 169–179. 58 indexed citations
13.
Zhao, Lu‐Jun, et al.. (2013). Identification of risk factors and characteristics of supraclavicular lymph node metastasis in patients with small cell lung cancer. Medical Oncology. 30(1). 493–493. 8 indexed citations
14.
Zhao, Lu‐Jun, et al.. (2013). Prognostic value of epidermal growth factor receptor mutations in resected lung adenocarcinomas. Medical Oncology. 31(1). 771–771. 46 indexed citations
15.
Meng, Mao-Bin, Nicholas G. Zaorsky, Chao Jiang, et al.. (2013). Radiotherapy and chemotherapy are associated with improved outcomes over surgery and chemotherapy in the management of limited-stage small cell esophageal carcinoma. Radiotherapy and Oncology. 106(3). 317–322. 58 indexed citations
16.
Zhao, Lu‐Jun, et al.. (2013). [Metastatic characteristics of lymph node in supraclavicular zone and radiotherapy target volume for limited-stage small cell lung cancer].. PubMed. 93(19). 1476–8. 2 indexed citations
17.
Meng, Maobin, Chao Jiang, Lijun Tian, et al.. (2012). Late course accelerated hyperfractionation radiotherapy for locally advanced esophageal squamous cell carcinoma. Thoracic Cancer. 4(2). 174–185.
18.
Zhuang, Hongqing, Jian Sun, Zhiyong Yuan, et al.. (2009). Radiosensitizing effects of gefitinib at different administration times in vitro. Cancer Science. 100(8). 1520–1525. 41 indexed citations
19.
Zhuang, Hongqing, et al.. (2009). The drug-resistance to gefitinib in PTEN low expression cancer cells is reversed by irradiation in vitro. Journal of Experimental & Clinical Cancer Research. 28(1). 123–123. 15 indexed citations
20.
Yuan, Zhiyong, et al.. (2004). [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].. PubMed. 26(7). 425–9. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huan-Huan Wang Breakdown of academic impact, for papers by Mao-Bin Meng Breakdown of academic impact, for papers by Dinu Stefan Breakdown of academic impact, for papers by Jun Sakakibara‐Konishi Breakdown of academic impact, for papers by Paul Lesueur Breakdown of academic impact, for papers by Jenny Ling‐Yu Chen Breakdown of academic impact, for papers by Qingting Huang Breakdown of academic impact, for papers by Irini Karapanagiotou‐Schenkel Breakdown of academic impact, for papers by László Mangel Breakdown of academic impact, for papers by M Slavík
Rankless by CCL
2026